AI applications are a promising solution for PAD that may translate into earlier detection, customized risk assessment, and improved outcomes.

A new in-depth report by The Insight Partners highlights chronic total occlusion market growth, driven by Rising Prevalence of ...

Alirocumab was found to have reduced cardiovascular events by 49.5% in patients with diabetes and by 42.3% in those without.

Reduced left ventricular ejection fraction and an increased extent of obstructive coronary artery disease signal an elevated ...

New CGuard Prime Carotid Stent System from InspireMD has a finer mesh that prevents plaque or clots from flowing into the ...

The updated plaque analysis technology is said to enhance coronary artery disease diagnosis with an improved algorithm.

This study adds a new layer to our understanding of heart health. It shows that heart attacks might not only be caused by ...

A common disease killing hundreds of thousands of Americans every year could be tied to a type of bacteria lurking in the ...

The Food and Drug Administration cleared Heartflow's technology to quantify coronary plaque and the platform is now available, the company said.

Advanced Provides Clarity in 3D Heartflow Plaque Analysis is the only FDA-cleared, AI-powered plaque quantification tool with a reported 95% agreement with the gold standard, IVUS, using blinded core ...

Dr. Peder Myhre: Welcome listeners to this week's issue of Circulation on the Run, the week of September 23. I am Dr. Peder ...

Ozzy Osbourne died on July 22, 2025, at age 76, but he's still top of mind for those who knew him best. That includes ...